Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03669718
Title A Randomized Phase 2 Study of Cemiplimab +/- ISA101b in HPV16-Positive OPC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ISA Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | HUN | GBR | FRA | ESP | DEU | CZE | BRA | BEL

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Moores Cancer Center at the UC San Diego Health San Diego California 92093 United States Details
University of California San Francisco San Francisco California 94115 United States Details
Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60208 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
ICAHN School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Cincinnati Cancer Institute Cincinnati Ohio 45069 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
M. D. Anderson Cancer Center Houston Texas 77030 United States Details
University Hospital Antwerp Antwerp Belgium Details
DFSATR/Oncologia D'Or Brasília Brazil Details
Instituto do Cancer do Estado de Sao Paulo Sao Paulo Brazil Details
University Hospital Olomouc Olomouc Czechia Details
Nemocnice na Bulovce Prague Czechia Details
Centre Léon Bérard Lyon France Details
CHU La Timone Marseille France Details
Antoine Lacassagne Center Nice France Details
Gustave Roussy Paris France Details
Hopitaux Universitaires Pitié Salpêtrière Charles Foix Paris France Details
Universitaetsklinikum Ulm Ulm Germany Details
Szabolcs Szatmar Bereg Megyei Korhazak Es Egyetemi Oktatokorhaz Nyiregyhaza Hungary Details
University of Pecs Department of Oncotherapy Pecs Hungary Details
Hetenyi Geza Korhaz-Rendelointezet Szolnok Hungary Details
ASST Spedali Civili Brescia, Department of Medical Oncology Brescia Italy Details
Azienda Ospedaliera San Paolo Polo Universitario Milan Italy Details
Istituto Nazionale dei Tumori Milan Italy Details
National Cancer Institute - IRCCS "Fondazione G. Pascale" Naples Italy Details
National Cancer Institute Regina Elena, IRCCS Rome Italy Details
Consultorio de Oncología Médica Oaxaca Mexico Details
Antoni van Leeuwenhoek Ziekenhuis Amsterdam 1066CX Netherlands Details
Radboud University Medical Center Nijmegen Netherlands Details
University Medical Center Utrecht Utrecht 3584 CX Netherlands Details
Maria Sklodowska-Curie National Institute of Oncology Gliwice Poland Details
Swietokrzyskie Oncology Center Kielce Kielce Poland Details
Hospital Clinic of Barcelona Barcelona Spain Details
Hospital Duran i Reynals - Institut Catala dOncologia ICO Barcelona Spain Details
Vall d'Hebron Barcelona Spain Details
Hospital Universitario Marqués de Valdecilla Santander Santander Spain Details
Aberdeen Royal Infirmary Aberdeen United Kingdom Details
The Royal Marsden NHS Foundation Chelsea United Kingdom Details
Guy's Hospital London United Kingdom Details
The Royal Marsden NHS Foundation Trust Sutton United Kingdom Details
Beacon Centre Musgrove Park Hospital Taunton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field